Lv4
410 积分 2023-10-07 加入
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
16小时前
待确认
混合型高脂血症基层诊疗中国专家共识（2024年）
12天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
16天前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
16天前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
16天前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study
17天前
已完结
Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice
29天前
已完结
GZR18, a novel long-acting GLP-1 analog, demonstrated positive in vitro and in vivo pharmacokinetic and pharmacodynamic characteristics in animal models
1个月前
已完结
A PPAR-alpha agonist and DPP-4 inhibitor mitigate adipocyte dysfunction in obese mice
1个月前
已完结
Grb10 and Grb14: enigmatic regulators of insulin action – and more?
2个月前
已完结
皖公网安备34019202002308
